HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution.

AbstractAIM:
To investigate the benefits of insulin like growth factor-1 (IGF-1) supplementation to serum-free institut georges lopez-1 (IGL-1) solution to protect fatty liver against cold ischemia reperfusion injury.
METHODS:
Steatotic livers were preserved for 24 h in IGL-1 solution supplemented with or without IGF-1 and then perfused "ex vivo" for 2 h at 37degrees C. We examined the effects of IGF-1 on hepatic damage and function (transaminases, percentage of sulfobromophthalein clearance in bile and vascular resistance). We also studied other factors associated with the poor tolerance of fatty livers to cold ischemia reperfusion injury such as mitochondrial damage, oxidative stress, nitric oxide, tumor necrosis factor-α (TNF-α) and mitogen-activated protein kinases.
RESULTS:
Steatotic livers preserved in IGL-1 solution supplemented with IGF-1 showed lower transaminase levels, increased bile clearance and a reduction in vascular resistance when compared to those preserved in IGL-1 solution alone. These benefits are mediated by activation of AKT and constitutive endothelial nitric oxide synthase (eNOS), as well as the inhibition of inflammatory cytokines such as TNF-α. Mitochondrial damage and oxidative stress were also prevented.
CONCLUSION:
IGL-1 enrichment with IGF-1 increased fatty liver graft preservation through AKT and eNOS activation, and prevented TNF-α release during normothermic reperfusion.
AuthorsMohamed Amine Zaouali, Susagna Padrissa-Altés, Ismail Ben Mosbah, Hassen Ben Abdennebi, Olivier Boillot, Antoni Rimola, Dalila Saidane-Mosbahi, Joan Roselló-Catafau
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 16 Issue 45 Pg. 5693-700 (Dec 07 2010) ISSN: 2219-2840 [Electronic] United States
PMID21128318 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • IGL-1 solution
  • Organ Preservation Solutions
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • Insulin-Like Growth Factor I
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Proto-Oncogene Proteins c-akt
  • Extracellular Signal-Regulated MAP Kinases
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Alanine Transaminase (metabolism)
  • Animals
  • Aspartate Aminotransferases (metabolism)
  • Bile (metabolism)
  • Cold Ischemia (adverse effects)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Fatty Liver (metabolism, pathology, surgery)
  • Insulin-Like Growth Factor I (pharmacology)
  • Liver (blood supply, drug effects, metabolism, pathology, surgery)
  • Mitochondria, Liver (drug effects, metabolism)
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase Type III (metabolism)
  • Organ Preservation Solutions (pharmacology)
  • Oxidative Stress (drug effects)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Rats
  • Rats, Zucker
  • Reperfusion Injury (etiology, metabolism, pathology, prevention & control)
  • Time Factors
  • Tumor Necrosis Factor-alpha (metabolism)
  • Vascular Resistance
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: